NCT01811459View on ClinicalTrials.gov

Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Delirium
Interventions
DRUG

Quetiapine

PO

DRUG

Haloperidol

IV

DRUG

Placebo

PO or IV

Trial Locations (1)

H2W 1T8

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
collaborator

Quebec Firefighters Foundation for Burns

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT01811459 - Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium | Biotech Hunter | Biotech Hunter